🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Status
Completed
Location
L-MARC Research Center
Start Date
2017-04-07
Trial ID
NCT03193047
Treatments Being Tested
This study will assess the safety, atorvastatin pharmacokinetics, and LDL-C...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01779453
Treatments Being Tested
The purpose of this study is to assess the low-density lipoprotein choleste...
Status
Completed
Location
Tokyo-Eki Center-Building Clinic
Start Date
2021-03-24
Trial ID
NCT04784442
The purpose of this study is to confirm the superiority of ETC-1002 after 1...
Status
Completed
Location
Rinku General Medical Center
Start Date
2023-02-13
Trial ID
NCT05683340
Treatments Being Tested
This study will assess the Low-Density Lipoprotein-Cholesterol (LDL-C) lowe...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-04
Trial ID
NCT01751984
The purpose of this study is to determine if bempedoic acid (ETC-1002) is e...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-16
Trial ID
NCT02988115
Treatments Being Tested
This Phase 1, double-blind (sponsor open) study will assess the safety, tol...
Status
Completed
Location
Jasper Clinic, Inc.
Start Date
2010-04-20
Trial ID
NCT01105598
Treatments Being Tested
The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe an...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-21
Trial ID
NCT02666664
This Phase 2 study will assess the efficacy and safety of ETC-1002 monother...
Status
Completed
Location
Multiple Locations
Start Date
2014-06-16
Trial ID
NCT02178098
A Multicenter, Open-label Study to assess the safety and efficacy of ETC-10...
Status
Completed
Location
Rinku General Medical Center
Start Date
2023-02-27
Trial ID
NCT05687071
Treatments Being Tested